Favre B, Turowski P, Hemmings B A
Friedrich Miescher-Institut, P. O. Box 2543, CH-4002 Basel, Switzerland.
J Biol Chem. 1997 May 23;272(21):13856-63. doi: 10.1074/jbc.272.21.13856.
Calyculin-A (CA), okadaic acid (OA), and tautomycin (TAU) are potent inhibitors of protein phosphatases 1 (PP1) and 2A (PP2A) and are widely used on cells in culture. Despite their well characterized selectivity in vitro, their exact intracellular effects on PP1 and PP2A cannot be directly deduced from their extracellular concentration because their cell permeation properties are not known. Here we demonstrate that, due to the tight binding of the inhibitors to PP1 and/or PP2A, their cell penetration could be monitored by measuring PP1 and PP2A activities in cell-free extracts. Treatment of MCF7 cells with 10 nM CA for 2 h simultaneously inhibited PP1 and PP2A activities by more than 50%. A concentration of 1 microM OA was required to obtain a similar time course of PP2A inhibition in MCF7 cells to that observed with 10 nM CA, whereas PP1 activity was unaffected. PP1 was predominantly inhibited in MCF7 cells treated with TAU but even at 10 microM TAU PP1 inhibition was much slower than that observed with 10 nM CA. Furthermore, binding of inhibitors to PP2Ac and/or PP1c in MCF7 cells led to differential posttranslational modifications of the carboxyl termini of the proteins as demonstrated by Western blotting. OA and CA, in contrast to TAU, induced demethylation of the carboxyl-terminal Leu309 residue of PP2Ac. On the other hand, CA and TAU, in contrast to OA, elicited a marked decrease in immunoreactivity of the carboxyl terminus of the alpha-isoform of PP1c, probably reflecting proteolysis of the protein. These results suggest that in MCF7 cells OA selectively inhibits PP2A and TAU predominantly affects PP1, a conclusion supported by their differential effects on cytokeratins in this cell line.
花萼海绵诱癌素A(CA)、冈田酸(OA)和 tautomycin(TAU)是蛋白磷酸酶1(PP1)和2A(PP2A)的强效抑制剂,广泛应用于细胞培养。尽管它们在体外具有明确的选择性,但由于其细胞渗透特性未知,无法直接从细胞外浓度推断其对PP1和PP2A的确切细胞内作用。在此,我们证明,由于抑制剂与PP1和/或PP2A紧密结合,可通过测量无细胞提取物中的PP1和PP2A活性来监测其细胞穿透情况。用10 nM CA处理MCF7细胞2小时,同时抑制PP1和PP2A活性超过50%。在MCF7细胞中,需要1 microM OA才能获得与10 nM CA观察到的类似的PP2A抑制时间进程,而PP1活性不受影响。在用TAU处理的MCF7细胞中,PP1主要受到抑制,但即使在10 microM TAU时,PP1的抑制也比10 nM CA观察到的慢得多。此外,通过蛋白质印迹法证明,抑制剂与MCF7细胞中的PP2Ac和/或PP1c结合导致蛋白质羧基末端的翻译后修饰存在差异。与TAU相反,OA和CA诱导PP2Ac羧基末端Leu309残基的去甲基化。另一方面,与OA相反,CA和TAU引起PP1cα异构体羧基末端免疫反应性的显著降低,这可能反映了该蛋白质的蛋白水解。这些结果表明,在MCF7细胞中,OA选择性抑制PP2A,TAU主要影响PP1,这一结论得到了它们对该细胞系细胞角蛋白的不同作用的支持。